April 3, 2012

Reproducibility

I think of reproducibility as Moffitt Cancer Center & Research Institute attempting to reproduce the features underlying the clinical value proposition of the principal investigators attempting to reproduce the features underlying the clinical value proposition Craig et al. produced.



Did Moffitt reproduce "much better efficacy" in demonstrating the bystander effect that the principal investigators reproduced in human trials that Craig et al. produced in murine trials and animal tumors?


Did Moffitt reproduce "much higher degree of tumor reduction" in demonstrating the bystander effect that the principal investigators reproduced in human trials that Craig et al. produced in murine trials and animal tumors?

Did Moffitt reproduce "both local and systemic effects on diseased tissue" in demonstrating the bystander effect that the principal investigators produced in human trials that Craig et al. produced in murine trials and animal tumors?

Yes, they did.


Were the above -- "much better efficacy," "much higher degree of tumor reduction" and "both local and systemic effects on diseased tissue" -- reproduced across different kinds of indications by Moffitt in demonstrating the bystander effect that different principal investigators reproduced in human trials that Craig et al. produced in murine trials and animal tumors?


We'll have to wait and see...

No comments:

Post a Comment